A New Era In Dry Eye Managemenet
Date: 17/08/2025 (AEST)
Venue: The Emerald Peacock, Peacock Lounge, Level 1, 233 Lonsdale st, Melbourne, VIC, 3000
Provider: Mentholatum Australasia Pty Ltd
Contact: Margaret Lam, [E] margaretlamoptometrist@gmail.com, [P] 0410663917
Activity Outline
A New Era In Dry Eye Management: A look at DEWS III and ROHTO Dry Aid
6.30pm to 9.30pm Sunday, 17th August, 2025
At the Emerald Peacock, 233 Lonsdale st, Melbourne VIC 3000
This dinner education event will explore the pathophysiology of dry eye, discussing DEWS III, neurosensory dysregulation and its role in dry eye. We will explore how the new DEWS III guidelines impact clinical application and how the use of ROHTO Dry Aid can alleviate dry eye disease.
Learning Objectives
- Discuss the evolving pathophysiology of dry eye - with a first time look at DEWS III, and also neurosensory dysregulation and its role in dry eye
- Describe the unique mechanism of action of ROHTO Dry Aid and its role in symptom modulation
- Identify the types of dry eye patients who may benefit most from ROHTO
- Integrate ROHTO into a tiered treatment algorithm for dry eye alongside existing therapies
Max CPD hours awarded: 1.5
Session Information
| Name |
|---|
| A New Era In Dry Eye Management - DEWS III |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.75 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.75 |
| Name |
|---|
| A New Era In Dry Eye Management - ROHTO |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.75 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.75 |